SCHEMBL740061

SCHEMBL740061

O=C1C2CCC1CC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1293264 0.89
SCHEMBL14787795 0.84 MAOA (0.35)
SCHEMBL10211862 0.78
SCHEMBL4750243 0.78
SCHEMBL6485310 0.75
SCHEMBL7527940 0.75
SCHEMBL30741886 0.75
Hydrochloric Acid SCHEMBL25259741 0.73 CHRNB4 (0.33)
SCHEMBL22734452 0.73 ESR2 (0.31)
Ethylene SCHEMBL1054747 0.73 MAPK1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250032408-A1 REACTIVE POLYMERS AND HYDROGELS FORMED FROM THE SAME BOSTON SCIENTIFIC SCIMED, INC. (US) 2025-01-30 US claimed
WO-2025024446-A1 REACTIVE POLYMERS AND HYDROGELS FORMED FROM THE SAME BOSTON SCIENTIFIC SCIMED, INC. (US) 2025-01-30 WO claimed
US-20030064948-A1 Invasomes for therapy of disorders, their preparation and use VECTRON THERAPEUTICS AG (DE) 2003-04-03 US claimed
WO-2002062316-A1 INVASOMES FOR THE TREATMENT OF DISEASE STATES, PRODUCTION AND USE THEREOF VECTRON THERAPEUTICS AG (DE) 2002-08-15 WO claimed
EP-1230917-A1 Invasomes for the therapy of illnesses, their manufacture and use Vectron Therapeutics AG (DE) 2002-08-14 EP claimed
EP-0293220-B1 Pharmacologically active 2-and 3-substituted (1', 5'-diaryl-3-pyrazolyl)-N-Hydroxypropanamides and method for synthesizing ORTHO PHARMA CORP (US) 1994-08-31 EP claimed
US-20250032408-A1 REACTIVE POLYMERS AND HYDROGELS FORMED FROM THE SAME BOSTON SCIENTIFIC SCIMED, INC. (US) 2025-01-30 US disclosed
WO-2025024446-A1 REACTIVE POLYMERS AND HYDROGELS FORMED FROM THE SAME BOSTON SCIENTIFIC SCIMED, INC. (US) 2025-01-30 WO disclosed
CN-118772168-A Synthesis method of bis (3-difluoromethylpyrazoline) 7-oxabicyclo [2, 1] heptane compound 西北师范大学 2024-10-15 CN disclosed
US-11932724-B1 High density polymers based on norbornadiene THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2024-03-19 US disclosed
US-20210338673-A1 MNK INHIBITORS AND METHODS RELATED THERETO EFFECTOR THERAPEUTICS INC (US) 2021-11-04 US disclosed
US-20210084900-A1 Substituted 5-(haloalkyl)-5-hydroxy-isoxazoles for Combating Phytopathogenic Fungi BASF SE (DE) 2021-03-25 US disclosed
US-20200190043-A1 2-[[5-(TRIFLUOROMETHYL)-1,2,4-OXADIAZOL-3-YL]ARYLOXY](THIO)ACETAMIDES FOR COMBATING PHYTOPATHOGENIC FUNGI BASF SE (DE) 2020-06-18 US disclosed
EP-1230917-A1 Invasomes for the therapy of illnesses, their manufacture and use Vectron Therapeutics AG (DE) 2002-08-14 EP disclosed
EP-0362771-B1 Use of photochromic substances RODENSTOCK OPTIK G (DE) 2000-05-31 EP disclosed
US-5637709-A Photochromatic substances OPTISCHE WERKE G. RODENSTOCK (DE) 1997-06-10 US disclosed
US-5608065-A ADAMANTANEOSPIRO-HETEROAROMATIC PYRANS OPTISCHE WERKE G. RODENSTOCK (DE) 1997-03-04 US disclosed
EP-0362771-A1 Photochromic substances Optische Werke G. Rodenstock (DE) 1990-04-11 EP disclosed
WO-1990003379-A1 PHOTOCHROMIC SUBSTANCES OPTISCHE WERKE G. RODENSTOCK (DE) 1990-04-05 WO disclosed
US-4064258-A Thiazole cardiovascular agents SYNTEX (U.S.A.) INC. (US) 1977-12-20 US disclosed